JP2023527385A5 - - Google Patents
Info
- Publication number
- JP2023527385A5 JP2023527385A5 JP2022572657A JP2022572657A JP2023527385A5 JP 2023527385 A5 JP2023527385 A5 JP 2023527385A5 JP 2022572657 A JP2022572657 A JP 2022572657A JP 2022572657 A JP2022572657 A JP 2022572657A JP 2023527385 A5 JP2023527385 A5 JP 2023527385A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030591P | 2020-05-27 | 2020-05-27 | |
| US63/030,591 | 2020-05-27 | ||
| PCT/US2021/034230 WO2021242848A1 (en) | 2020-05-27 | 2021-05-26 | Anti-gd2 sada conjugates and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527385A JP2023527385A (ja) | 2023-06-28 |
| JPWO2021242848A5 JPWO2021242848A5 (https=) | 2024-06-03 |
| JP2023527385A5 true JP2023527385A5 (https=) | 2024-06-03 |
Family
ID=78722708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572657A Pending JP2023527385A (ja) | 2020-05-27 | 2021-05-26 | 抗ｇｄ２ ｓａｄａコンジュゲート及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230235087A1 (https=) |
| EP (1) | EP4157293A4 (https=) |
| JP (1) | JP2023527385A (https=) |
| CN (1) | CN116194133A (https=) |
| AU (1) | AU2021280272A1 (https=) |
| CA (1) | CA3180445A1 (https=) |
| WO (1) | WO2021242848A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11583588B2 (en) * | 2017-05-05 | 2023-02-21 | Memorial Sloan Kettering Cancer Center | Modular self assembly disassembly (SADA) technologies |
| EP4448565A1 (en) | 2021-12-15 | 2024-10-23 | Y-Mabs Therapeutics, Inc. | Scfv and antibodies with reduced multimerisation |
| JP2024546804A (ja) * | 2021-12-15 | 2024-12-26 | ワイ－マブス セラピューティクス， インコーポレイテッド | Ｓａｄａ複合体を含む製剤 |
| US20260021206A1 (en) * | 2022-07-25 | 2026-01-22 | Vironexis Biotherapeutics Inc. | Adeno-associated virus vectors and methods of their use for reducing the risk of, treating, and preventing metastasis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6962702B2 (en) * | 1998-06-22 | 2005-11-08 | Immunomedics Inc. | Production and use of novel peptide-based agents for use with bi-specific antibodies |
| US20060057062A1 (en) * | 2004-09-10 | 2006-03-16 | Trotter Dinko G | Compositions and methods useful in pretargeted imaging |
| US11583588B2 (en) * | 2017-05-05 | 2023-02-21 | Memorial Sloan Kettering Cancer Center | Modular self assembly disassembly (SADA) technologies |
| US11565005B2 (en) * | 2017-07-06 | 2023-01-31 | Memorial Sloan Kettering Cancer Center | Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy |
| EP3765031A4 (en) * | 2018-03-14 | 2022-03-23 | Memorial Sloan Kettering Cancer Center | ANTI-POLYSIAL ACID ANTIBODIES AND USES THEREOF |
| AU2020225631A1 (en) * | 2019-02-22 | 2021-09-16 | Memorial Sloan Kettering Cancer Center | CD33 antibodies and methods of using the same to treat cancer |
| EP3938400B1 (en) * | 2019-03-11 | 2025-07-30 | Memorial Sloan Kettering Cancer Center | Cd22 antibodies and methods of using the same |
| CN114401744B (zh) * | 2019-06-26 | 2024-11-05 | 纪念斯隆凯特琳癌症中心 | 用于治疗癌症的抗cd33抗体 |
-
2021
- 2021-05-26 WO PCT/US2021/034230 patent/WO2021242848A1/en not_active Ceased
- 2021-05-26 AU AU2021280272A patent/AU2021280272A1/en active Pending
- 2021-05-26 CN CN202180059161.6A patent/CN116194133A/zh active Pending
- 2021-05-26 CA CA3180445A patent/CA3180445A1/en active Pending
- 2021-05-26 JP JP2022572657A patent/JP2023527385A/ja active Pending
- 2021-05-26 EP EP21812276.0A patent/EP4157293A4/en active Pending
- 2021-05-26 US US17/999,786 patent/US20230235087A1/en active Pending